Global Toolkit on Treatment Demand Data

State of Progress

Michael Donmall(Co-ordinator Joint Project)

National DrugEvidence Centre

• TDI – EMCDDA-Pompidou Group Protocol– European harmonisation– Potential for wider application

• GAP – improve global information on drug consumption– Governments committed to measurable results demand

reduction by 2008– Need reliable & systematic data at global level– Assist governments in compiling comparable data– Collect, summarise, analyse & report data to Commission

Narcotic Drugs– INRA

• UNODC/ EMCDDA 2003 – joint initiative established– Define workable & practical toolkit– Harmonisation - comparative international work

National DrugEvidence Centre

Background

• Definitional issues– Treatment, cases, episodes, core data set

• Technical matters– Quality control, double counting, data capture

• Development– Need and purpose

• Implementation– in context of local, national & international needs

• Analysis & dissemination• Clarity• Importance of being a collaborative exercise

National DrugEvidence Centre

Common issues that need structured guidance over wide area

• Opportunity to discuss & share experiences of practicalities of implementing Treatment Information Systems

• Explore basic rationale behind collection of such information

• Role and utility

• Strengths and limitations– As epidemiological tool

– In performance management

• Define in broad terms the requirements of

a global toolkit National Drug

Evidence Centre

Global Workshop on Treatment Demand Indicators, Vienna 2003

• Project Team:• Michael Donmall National Drug Evidence Centre, Manchester, UK• Linda Montanari EMCDDA, Portugal• Stefano Berterame UNODC. Austria

• Meeting Participants:• Stefano Berterame UNODC, Austria• Luis Caris CICAD, Chile• Michael Donmall National Drug Evidence Centre, UK• Leigh Henderson SAMHSA, USA• Douglas Ken-Garfield CAREC, Republic of Trinidad and Tobago• Peter Lawrinson National Drug and Alcohol Research Centre, Australia• Riku Lehtovuori UNODC, Austria• Jean Long Pompidou Group. Ireland• Linda Montanari EMCDDA, Portugal• Visweswaran Navaratnam National Centre for Drug Research, Malaysia• Kamran Niaz UNODC, Turkey• Isidore S. Obot WHO, Switzerland• Charles Parry SENDU, South Africa• Luis Royuela Morales Plan Nacional sobre Drogas, Spain• Brian Rush Centre for Addiction and Mental Health, Canada• Bela Studnikova Drug Epidemiology Headquarters, Czech Republic• Fayzel Sulliman Dr Idrice Goomany Centre Mauritius • Juana Tomas-RosselloUNODC, Austria• Matthew Warner-SmithUNODC, Egypt

National DrugEvidence Centre

EMCDDA Project CT.03.ENL.209

FINAL REPORT & PROPOSED OUTLINE GLOBAL TOOLKITFOR THE MEASUREMENT OF DRUG TREATMENT DEMAND

BACKGROUND MATERIAL FOR THE DEVELOPMENT OF A TOOLKIT ON DATA COLLECTION REGARDING DRUG TREATMENT DEMAND IN THE EUROPEAN MEMBER STATES AND IN THE ACCEDING AND CANDIDATE COUNTRIES

INCLUDING MEETING REPORT OF THE GLOBAL WORKSHOP ON TREATMENT DEMAND INDICATORS VIENNA INTERNATIONAL CENTRE, DECEMBER 2003

National

Drug

Evidence

Centre

University of Manchester

National DrugEvidence Centre

Proposed Toolkit Structure

1 Introduction 1.1 Aims 1.2 Readership 1.3 Main Features & Roadmap

2 Overview: reasons for collecting drug treatment data 2.1 Why a system of treatment data collection is useful

• For epidemiological and/or performance management• As an indirect indicator of trends in problem drug use• For identifying patterns of drug use• As a basis for other methodologies (eg incidence)• For policy and advocacy• To identify patterns of use of services• For plans and service evaluation• Other purposes

2.2 Limitations

National DrugEvidence Centre

Proposed Toolkit Structure

3 Building your foundation 3.1 Scoping – comparison between systems 3.2 Information, Needs and Resources Assessment (INRA) 3.3 Organisational Issues

• Gaining political support• Identifying stakeholders• Location• Funding

3.4 Inventory of services & describe treatment system

4 Data to be collected 4.1 Guiding principles 4.2 The core item list  4.3 Core Definitions

• Case definition• Treatment, treatment demand, type, episode• Item definitions and valid codes

4.4 Core information requirement at a global level 4.5 Case Studies

National DrugEvidence Centre

Proposed Toolkit Structure

5 Implementing a Treatment Demand Indicator System 5.1 Planning and development

• People/ network issues• Procedures• Technical Issues• Ethical Issues• Planning use of data

5.2 Data collection• Establishing process• Data checking, validation & ongoing audit

5.3 Data quality & Coverage 5.5 Case Studies

6 Analysing and Reporting on the Results 6.1 Data Analysis & Interpretation 6.2 Reporting 6.3 Case Studies

National DrugEvidence Centre

Proposed Toolkit Structure

7 Maintenance & Evaluation 7.1 Maintenance 7.2 Evaluation

GlossaryBibliography

Appendix A Sample Materials

• Data collection sheets• Reports• Validation rules

B Frequently Asked Questions (FAQs) C Links to relevant Web Addresses D Key Toolkit Markers (PowerPoint)